NCI study: COVID-19 was third leading cause of death in the U.S. in 2020 and 2021

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

To help accelerate research into new treatments for acute myeloid leukemia and myelodysplastic syndrome, Thermo Fisher Scientific Inc. is partnering with NCI on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

July 26, 2024

Vol.50 No.30

Conversation with The Cancer Letter

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

What can NCI accomplish in data science?

July 12, 2024

Vol.50 No.28

By Paul Goldberg

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

Kate Choi grew up hearing conversations about skin cancer. Her grandparents had it, as did her cousins.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

Clinical

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Cancer centers that continue to experience pandemic-induced shortages in staffing their clinical research enterprise may soon be able to rely on support from NCI’s Virtual Clinical Trials Office to open studies and accrue patients.

June 28, 2024

Vol.50 No.26

By Matthew Bin Han Ong

Obituary

Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82

Edward Sondik, an electrical engineer by training, followed a career path that led him to top public health positions.He was a director of the National Center for Health Statistics at CDC, an acting director of NCI, and a deputy director of the NCI Division of Cancer Prevention and Control.

June 28, 2024

Vol.50 No.26

By Jacquelyn Cobb

BSA approves five new, 17 reissue concepts

The NCI Board of Scientific Advisors approved five new concepts and 17 reissue concepts at a joint meeting of the BSA and the National Cancer Advisory Board June 11-12.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

NCI study: COVID-19 was third leading cause of death in the U.S. in 2020 and 2021

YOU MAY BE INTERESTED IN

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82

BSA approves five new, 17 reissue concepts

Renew today!

Subscriber content

Login

NCI study: COVID-19 was third leading cause of death in the U.S. in 2020 and 2021

YOU MAY BE INTERESTED IN

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forwardNCI’s Youth Enjoy Science (YES) program also invests in student scientists

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82

BSA approves five new, 17 reissue concepts

Login

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists